» Articles » PMID: 17948334

Mechanisms of Sepsis-induced Organ Dysfunction

Overview
Journal Crit Care Med
Date 2007 Oct 20
PMID 17948334
Citations 152
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The past several years have seen remarkable advances in understanding the basic cellular and physiologic mechanisms underlying organ dysfunction and recovery relating to sepsis. Although several new therapeutic approaches have improved outcome in septic patients, the far-reaching potential of these new insights into sepsis-associated mechanisms is only beginning to be realized.

Aim: The Brussels Round Table Conference in 2006 convened >30 experts in the field of inflammation and sepsis to review recent advances involving sepsis and to discuss directions that the field is likely to take in the near future.

Findings: Current understanding of the pathophysiology underlying sepsis-induced multiple organ dysfunction highlights the multiple cell populations and cell-signaling pathways involved in this complex condition. There is an increasing appreciation of interactions existing between different cells and organs affected by the septic process. The intricate cross-talk provided by temporal changes in mediators, hormones, metabolites, neural signaling, alterations in oxygen delivery and utilization, and by modifications in cell phenotypes underlines the adaptive and even coordinated processes beyond the dysregulated chaos in which sepsis was once perceived. Many pathologic processes previously considered to be detrimental are now viewed as potentially protective. Applying systems approaches to these complex processes will permit better appreciation of the effectiveness or harm of treatments, both present and future, and also will allow development not only of better directed, but also of more appropriately timed, strategies to improve outcomes from this still highly lethal condition.

Citing Articles

Renal Expression Levels of C5a Receptor and Autophagy-related Beclin-1 and LC3A/B Are Simultaneously Enhanced Under Immunoglobulin Treatment in a Rat Model of Sepsis.

Polat O, Orhun G, Anakli I, Yilmaz V, Koral G, Ulusoy C In Vivo. 2025; 39(2):810-818.

PMID: 40010959 PMC: 11884498. DOI: 10.21873/invivo.13883.


Lactate Clearance of the Adsorber Cytosorb in Critically Ill Patients: A Post-Hoc Analysis of the Cyto-SOLVE Trial.

Wustrow V, Grafe C, Graf H, Scheiermann P, Paal M, Vogeser M Biomedicines. 2025; 13(2).

PMID: 40002832 PMC: 11853421. DOI: 10.3390/biomedicines13020418.


Pathologic function and therapeutic potential of extracellular vesicle miRNA in sepsis.

Deng R, Cui X, Zhang R, Liu C, Luo J, Liu L Front Pharmacol. 2025; 15:1452276.

PMID: 39744123 PMC: 11688188. DOI: 10.3389/fphar.2024.1452276.


CircRBM33 competitively binds miR-15a-5p to mediate EZH1 expression to ameliorate sepsis-induced acute lung injury.

Lin J, Wei Q, Fang Z Clinics (Sao Paulo). 2024; 80:100550.

PMID: 39667201 PMC: 11699051. DOI: 10.1016/j.clinsp.2024.100550.


C5a Induces Inflammatory Signaling and Apoptosis in PC12 Cells through C5aR-Dependent Signaling: A Potential Mechanism for Adrenal Damage in Sepsis.

Mrozewski L, Tharmalingam S, Michael P, Kumar A, Tai T Int J Mol Sci. 2024; 25(19).

PMID: 39409001 PMC: 11477224. DOI: 10.3390/ijms251910673.